Performance characteristics of the Access® Inhibin A assay

Clinica Chimica Acta

Volumn 397, Issue 1-2, 2008, Pages 32-35

  Rawlins, Mindy L ^a   La'ulu, Sonia L ^a   Erickson, J Alan ^a   Roberts, William L ^b  

^a ARUP INSTITUTE FOR CLINICAL AND EXPERIMENTAL PATHOLOGY   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Immunoassay; Imprecision; Inhibin A; Interferences; Linearity; Method comparison

Indexed keywords

BILIRUBIN; HEMOGLOBIN; INHIBIN A; TRIACYLGLYCEROL;

ACCURACY; ANALYTIC METHOD; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; MALE; PERFORMANCE; PRIORITY JOURNAL;

DOWN SYNDROME; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INHIBINS; MALE; OVARIAN NEOPLASMS; PREGNANCY; PRENATAL DIAGNOSIS; REPRODUCIBILITY OF RESULTS; TESTICULAR NEOPLASMS;

EID: 51249103182     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2008.07.013     Document Type: Article

References (13)

1. Haddow J.E., Palomaki G.E., Knight G.J., Foster D.L., and Neveux L.M. Second trimester screening for Down's syndrome using maternal serum dimeric inhibin A. J Med Screen 5 (1998) 115-119
2. Lockwood G.M., Muttukrishna S., and Ledger W.L. Inhibins and activins in human ovulation, conception and pregnancy. Hum Reprod Update 4 (1998) 284-295
3. Muttukrishna S. Role of inhibin in normal and high-risk pregnancy. Semin Reprod Med 22 (2004) 227-234
4. Aitken D.A., Wallace E.M., Crossley J.A., et al. Dimeric inhibin A as a marker for Down's syndrome in early pregnancy. N Engl J Med 334 (1996) 1231-1236
5. Palomaki G.E., Lambert-Messerlian G.M., and Canick J.A. A summary analysis of Down syndrome markers in the late first trimester. Adv Clin Chem 43 (2007) 177-210
6. Malone F.D., Canick J.A., Ball R.H., et al. First-trimester or second-trimester screening, or both, for Down's syndrome. N Engl J Med 353 (2005) 2001-2011
7. Robertson D.M., Cahir N., Burger H.G., Mamers P., and Groome N. Inhibin forms in serum from postmenopausal women with ovarian cancers. Clin Endocrinol (Oxf) 50 (1999) 381-386
8. Iczkowski K.A., Bostwick D.G., Roche P.C., and Cheville J.C. Inhibin A is a sensitive and specific marker for testicular sex cord-stromal tumors. Mod Pathol 11 (1998) 774-779
9. Owen W.E., Roberts R.F., and Roberts W.L. Performance characteristics of the LiBASys((R)) des-gamma-carboxy prothrombin assay. Clin Chim Acta 389 (2008) 183-185
10. Erickson J.A., Ashwood E.R., and Gin C.A. Evaluation of a dimeric inhibin-A assay for assessing fetal Down syndrome: establishment, comparison, and monitoring of median concentrations for normal pregnancies. Arch Pathol Lab Med 128 (2004) 415-420
11. Harrison G., and Goldie D. Second-trimester Down's syndrome serum screening: double, triple or quadruple marker testing?. Ann Clin Biochem 43 (2006) 67-72
12. Lambert-Messerlian G., Bandera C., Eklund E., Neuhauser A., and Canick J. Very high inhibin A concentration attributed to heterophilic antibody interference. Clin Chem 53 (2007) 800-801
13. Lambert-Messerlian G.M., Palomaki G.E., and Canick J.A. Inhibin A measurement using an automated assay platform. Prenat Diagn 28 (2008) 399-403